Although LCN2 has been reported to be involved in iron homeostasis and immune regulation in various types of cancer, its function in osteosarcoma remains insufficiently studied, and its role as a downstream target of SPI1 in the regulation of ferroptosis has not been clearly elucidated. This evidence concerns the gene LCN2 and osteosarcoma.